3200 Lakeside Dr.
Santa Clara
CA
95054
USA
(408) 845-3000
Related Content
Feb. 7, 2007 — Abbott has announced its plan to launch the world's first drug-eluting stent clinical trial solely in ...
February 06, 2007
Jan. 29, 2007 — Abbott Vascular surpassed Cordis for the first time in December 2006 as the market leader in peripheral ...
January 28, 2007Jan. 5, 2007 — A French court has ruled that Abbott Laboratories’ Xience V drug-eluting coronary stents infringe patents ...
January 04, 2007
The Emboshield PRO Embolic Protection System received CE approval and will be launched in Europe. Embolic protection ...
November 15, 2006A subset analysis of diabetic patients in the SPIRIT II Clinical trial of the XIENCE V Everolimus Eluting Stent System ...
October 30, 2006Abbott Vascular says it will begin launching its XIENCE V stent system immediately in most European countries, focusing ...
October 04, 2006The i-STAT BNP cartridge is a point of care diagnostic test used to assess the level of BNP (brain naturietic peptide) ...
August 29, 2006
Abbott Vascular has two embolic protection systems: the Emboshield and the RX ACCUNET. A filter-based device, Emboshield ...
August 29, 2006
Engineered specifically for the carotid artery, Xact’s closed-cell, tight-mesh design allows for a high coverage area ...
June 29, 2006
Abbott received FDA clearance to market its StarClose Vascular Closure System, a new vessel closure device engineered to ...
June 29, 2006